DHA phase i small business technology transfer progream (sttr) proposal titled: high-throughput organoid screening platform for investigating novel traumatic brain injury therapeutics
Ended Purchase Order Awarded
- Contract number
- HT942525P0066
- Awardee
-
Protein Fluidics Inc. UEI L6L8K3CBAGP7
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $249,860
Award facts
- Opportunity
-
- HQ003420RBDST Solicitation number
- Contract value 100% obligated
- $249,859.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 12 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Redwood City, CA, USA
- Research
- STTR Phase I
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
About this award
Protein Fluidics Inc., a small business located in Redwood City, California, was awarded a $249,860 contract by the Defense Health Agency under the Small Business Technology Transfer (STTR) Program Phase I. The award, made on June 4, 2025, is designated as a Total Small Business set-aside and structured as a firm fixed price purchase order. The contract will support research and development of a high-throughput organoid screening platform designed to investigate novel therapeutics for traumatic brain injury treatment, with work expected to conclude by January 3, 2026.
STTR Phase I awards are designed to support small businesses partnering with research institutions to explore the feasibility of innovative technologies with potential federal application. In this case, Protein Fluidics' platform represents an advancement in biomedical research capabilities that could enhance the Defense Health Agency's capacity to evaluate and develop new treatment approaches for traumatic brain injury—a significant health concern for the military population. The relatively modest contract ceiling reflects the exploratory nature of Phase I research, which typically demonstrates proof of concept before advancement to larger Phase II or Phase III development efforts.
Quick answers
Who was awarded contract HT942525P0066?
HT942525P0066 was awarded to Protein Fluidics Inc. by Defense Health Agency (Department of Defense) on June 4, 2025.
How much is contract HT942525P0066 worth?
The government has obligated $249,860 on HT942525P0066.
Was contract HT942525P0066 competed?
The extent of competition for HT942525P0066 was full and open competition after exclusion of sources. The government received 12 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award